Cargando…

Detection of adamantane-sensitive influenza A(H3N2) viruses in Australia, 2017: a cause for hope?

For over a decade virtually all A(H3N2) influenza viruses have been resistant to the adamantane class of antivirals. However, during the 2017 influenza season in Australia, 15/461 (3.3%) adamantane-sensitive A(H3N2) viruses encoding serine at residue 31 of the M2 protein were detected, more than the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hurt, Aeron, Komadina, Naomi, Deng, Yi-Mo, Kaye, Matthew, Sullivan, Sheena, Subbarao, Kanta, Barr, Ian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Centre for Disease Prevention and Control (ECDC) 2017
Materias:	Rapid Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5710658/ https://www.ncbi.nlm.nih.gov/pubmed/29183552 http://dx.doi.org/10.2807/1560-7917.ES.2017.22.47.17-00731

Ejemplares similares

Low interim influenza vaccine effectiveness, Australia, 1 May to 24 September 2017
por: Sullivan, Sheena G, et al.
Publicado: (2017)

Where has all the influenza gone? The impact of COVID-19 on the circulation of influenza and other respiratory viruses, Australia, March to September 2020
por: Sullivan, Sheena G, et al.
Publicado: (2020)

Locally Acquired Human Infection with Swine-Origin Influenza A(H3N2) Variant Virus, Australia, 2018
por: Deng, Yi-Mo, et al.
Publicado: (2020)

Intense interseasonal influenza outbreaks, Australia, 2018/19
por: Barr, Ian G, et al.
Publicado: (2019)

Comparative epidemiology, phylogenetics, and transmission patterns of severe influenza A/H3N2 in Australia from 2003 to 2017
por: Xia, Jing, et al.
Publicado: (2020)

The impact of climate and antigenic evolution on seasonal influenza virus epidemics in Australia
por: Lam, Edward K. S., et al.
Publicado: (2020)

The re-emergence of influenza following the COVID-19 pandemic in Victoria, Australia, 2021 to 2022
por: Pendrey, Catherine GA, et al.
Publicado: (2023)

Effect of Baloxavir and Oseltamivir in Combination on Infection with Influenza Viruses with PA/I38T or PA/E23K Substitutions in the Ferret Model
por: Koszalka, Paulina, et al.
Publicado: (2022)

Heterogeneity in influenza seasonality and vaccine effectiveness in Australia, Chile, New Zealand and South Africa: early estimates of the 2019 influenza season
por: Sullivan, Sheena G, et al.
Publicado: (2019)

Inter-Seasonal Influenza is Characterized by Extended Virus Transmission and Persistence
por: Patterson Ross, Zoe, et al.
Publicado: (2015)

Peramivir and laninamivir susceptibility of circulating influenza A and B viruses
por: Leang, Sook-Kwan, et al.
Publicado: (2014)

Influenza Virus Transmission from Horses to Dogs, Australia
por: Kirkland, Peter D., et al.
Publicado: (2010)

Epidemiology of repeat influenza infection in Queensland, Australia, 2005–2017
por: Price, Olivia, et al.
Publicado: (2022)

Performance of influenza rapid point‐of‐care tests in the detection of swine lineage A(H1N1) influenza viruses
por: Hurt, Aeron C., et al.
Publicado: (2009)

A Novel Video Tracking Method to Evaluate the Effect of Influenza Infection and Antiviral Treatment on Ferret Activity
por: Oh, Ding Yuan, et al.
Publicado: (2015)

Interim effectiveness of trivalent influenza vaccine in a season dominated by lineage mismatched influenza B, northern Spain, 2017/18
por: Castilla, Jesús, et al.
Publicado: (2018)

Interim estimate of influenza vaccine effectiveness in hospitalised children, Hong Kong, 2017/18
por: Chiu, Susan S, et al.
Publicado: (2018)

Excess all-cause and influenza-attributable mortality in Europe, December 2016 to February 2017
por: Vestergaard, Lasse S, et al.
Publicado: (2017)

Influenza A(H3N2) virus variants and patient characteristics during a summer influenza epidemic in Taiwan, 2017
por: Tsou, Tsung-Pei, et al.
Publicado: (2017)

The significance of increased influenza notifications during spring and summer of 2010–11 in Australia
por: Kelly, Heath A., et al.
Publicado: (2012)

Influenza Virus A (H10N7) in Chickens and Poultry Abattoir Workers, Australia
por: Arzey, George G., et al.
Publicado: (2012)

Interim 2017/18 influenza seasonal vaccine effectiveness: combined results from five European studies
por: Rondy, Marc, et al.
Publicado: (2018)

Antiviral Therapy for the Next Influenza Pandemic
por: Hurt, Aeron C.
Publicado: (2019)

Assessing baloxavir susceptibility of influenza viruses circulating in the United States during the 2016/17 and 2017/18 seasons
por: Gubareva, Larisa V, et al.
Publicado: (2019)

Interim estimates of 2016/17 vaccine effectiveness against influenza A(H3N2), Canada, January 2017
por: Skowronski, Danuta M, et al.
Publicado: (2017)

Emergence of a novel subclade of influenza A(H3N2) virus in London, December 2016 to January 2017
por: Harvala, Heli, et al.
Publicado: (2017)

Epidemiology of human infections with highly pathogenic avian influenza A(H7N9) virus in Guangdong, 2016 to 2017
por: Kang, Min, et al.
Publicado: (2017)

Evolution and international transmission of H3N2 canine influenza A viruses from Korea during 2014–2017
por: Lee, Chung-Young
Publicado: (2023)

Surveillance and Analysis of Avian Influenza Viruses, Australia
por: Hansbro, Philip M., et al.
Publicado: (2010)

Infection with different human influenza A subtypes affects the period of susceptibility to secondary bacterial infections in ferrets
por: Mifsud, Edin J, et al.
Publicado: (2022)

Circulation and characterization of seasonal influenza viruses in Cambodia, 2012‐2015
por: Horwood, Paul F., et al.
Publicado: (2019)

Dominant influenza A(H3N2) and B/Yamagata virus circulation in EU/EEA, 2016/17 and 2017/18 seasons, respectively
por: Adlhoch, Cornelia, et al.
Publicado: (2018)

Pathogenicity and genetic characterisation of a novel reassortant, highly pathogenic avian influenza (HPAI) H5N6 virus isolated in Korea, 2017
por: Kim, Young-Il, et al.
Publicado: (2018)

Biological characterisation of the emerged highly pathogenic avian influenza (HPAI) A(H7N9) viruses in humans, in mainland China, 2016 to 2017
por: Zhu, Wenfei, et al.
Publicado: (2017)

Debate Regarding Oseltamivir Use for Seasonal and Pandemic Influenza
por: Hurt, Aeron C., et al.
Publicado: (2016)

Low 2016/17 season vaccine effectiveness against hospitalised influenza A(H3N2) among elderly: awareness warranted for 2017/18 season
por: Rondy, Marc, et al.
Publicado: (2017)

Early season co-circulation of influenza A(H3N2) and B(Yamagata): interim estimates of 2017/18 vaccine effectiveness, Canada, January 2018
por: Skowronski, Danuta M, et al.
Publicado: (2018)

Antibody titres elicited by the 2018 seasonal inactivated influenza vaccine decline by 3 months post‐vaccination but persist for at least 6 months
por: Mordant, Francesca L., et al.
Publicado: (2022)

Assessment of the RNASound RNA Sampling Card for the Preservation of Influenza Virus RNA
por: Lau, Hilda, et al.
Publicado: (2016)

Adamantane-Resistant Influenza Infection During the 2004–05 Season
por: Rahman, Mahbubur, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_n52q1tv063ksftpkl7qkrmv7i7